Thai Nguyen City

Resilience Network


You are here

Vaccines delivered under COVAX sharing scheme for poorer countries --data

Primary tabs

March 4 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.34 billion COVID-19 vaccine doses to 144 countries, GAVI data shows.

In December COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.

The following tables list countries that have received vaccines under the scheme, sorted alphabetically:

AFRICA & MIDDLE EAST

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Algeria
3.6 million
December 24
J&J
44 million
6.0 million
Angola
801,000
December 25
Pfizer/BioNTech
33 million
14.8 million
Benin
336,000
November 4
J&J
12 million
1.1 million
Botswana
300,000
October 1
AstraZeneca/Oxford
2.5 million
560,460
Burkina Faso
504,000
December 22
J&J
21 million
1.1 million
Cameroon
336,000
November 5
J&J
27 million
1.0 million
Cape Verde
200,000
December 7
Pfizer/BioNTech
556,000
324,000
Central African Republic
168,300
November 19
J&J
4.8 million
806,700
Chad
117,000
October 5
Pfizer/BioNTech
16 million
217,620
Comoros Islands
12,000
April 12
AstraZeneca/Oxford
870,000
12,000
Congo
168,000
November 15
J&J
5.5 million
470,400
Democratic Republic of Congo
349,830
October 21
Pfizer/BioNTech
90 million
2.6 million
Djibouti
151,200
July 17
J&J
988,000
175,200
Egypt
2.2 million
February 20
Pfizer/BioNTech
102 million
29.0 million
Eswatini
100,620
October 6
Pfizer/BioNTech
1.1 million
429,420
Ethiopia
13.1 million
February 2
J&J
115 million
27.5 million
Gabon
101,790
November 1
Pfizer/BioNTech
2.2 million
370,410
Gambia
100,620
March 3
Pfizer/BioNTech
2.4 million
477,420
Ghana
1.7 million
December 24
Pfizer/BioNTech
31 million
16.3 million
Guinea
168,000
November 14
J&J
13 million
1.7 million
Guinea-Bissau
28,800
August 18
AstraZeneca/Oxford
2.0 million
360,000
Iran
700,000
January 14
AstraZeneca/Oxford
84 million
5.7 million
Iraq
500,000
August 14
Pfizer/BioNTech
40 million
836,000
Ivory Coast
816,660
January 3
Pfizer/BioNTech
26 million
8.6 million
Jordan
146,400
June 3
AstraZeneca/Oxford
10 million
436,800
Kenya
1.9 million
February 28
Pfizer/BioNTech
54 million
18.6 million
Lebanon
613,340
December 22
N/A
6.8 million
982,940
Lesotho
169,070
November 19
J&J
2.1 million
644,090
Liberia
168,000
November 27
J&J
5.1 million
830,400
Libya
1.2 million
December 20
Pfizer/BioNTech
6.9 million
1.9 million
Madagascar
240,000
February 17
J&J
28 million
1.9 million
Malawi
277,080
February 26
AstraZeneca/Oxford
19 million
2.0 million
Mali
50,400
January 7
AstraZeneca/Oxford
20 million
1.7 million
Mauritania
201,600
February 7
AstraZeneca/Oxford
4.6 million
2.2 million
Mauritius
203,580
January 12
Pfizer/BioNTech
1.3 million
387,270
Morocco
1.5 million
January 29
Pfizer/BioNTech
37 million
2.7 million
Mozambique
1.2 million
February 11
AstraZeneca/Oxford
31 million
8.4 million
Namibia
19,890
February 18
Pfizer/BioNTech
2.5 million
512,690
Niger
398,000
February 4
Pfizer/BioNTech
24 million
1.6 million
Nigeria
2.0 million
February 7
J&J
206 million
17.2 million
Palestinian Territories
203,580
January 31
Pfizer/BioNTech
4.7 million
1.3 million
Rwanda
1.1 million
January 15
N/A
13 million
3.9 million
Sao Tome and Principe
24,000
March 3
AstraZeneca/Oxford
219,000
24,000
Senegal
302,400
February 10
J&J
17 million
3.2 million
Seychelles
39,780
December 17
Pfizer/BioNTech
98,460
74,880
Sierra Leone
168,000
November 23
J&J
8.0 million
785,310
Somalia
250,380
March 3
Pfizer/BioNTech
16 million
1.4 million
South Africa
5.6 million
July 31
Pfizer/BioNTech
59 million
5.6 million
South Sudan
336,000
December 21
J&J
11 million
908,450
Sudan
604,800
February 16
J&J
44 million
3.9 million
Syria
4.0 million
January 26
J&J
17 million
5.7 million
Tanzania
1.6 million
January 19
Pfizer/BioNTech
60 million
4.7 million
Togo
633,600
November 25
J&J
8.3 million
3.0 million
Tunisia
310,050
January 28
Pfizer/BioNTech
12 million
4.4 million
Uganda
433,300
February 16
Moderna
46 million
11.7 million
Yemen
100,800
February 24
AstraZeneca/Oxford
30 million
2.2 million
Zambia
907,200
January 28
N/A
18 million
4.0 million
Zimbabwe
2.6 million
January 19
N/A
15 million
3.5 million

EUROPE

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Albania
40,800
June 2
AstraZeneca/Oxford
2.8 million
120,000
Armenia
187,200
September 5
AstraZeneca/Oxford
3.0 million
261,200
Azerbaijan
84,000
April 4
AstraZeneca/Oxford
10 million
84,000
Bosnia
32,760
May 10
Pfizer/BioNTech
3.3 million
82,560
Georgia
43,200
March 13
AstraZeneca/Oxford
3.7 million
43,200
Kosovo
515,970
February 10
Pfizer/BioNTech
1.8 million
1.2 million
Moldova
100,620
January 27
Pfizer/BioNTech
2.6 million
744,620
Montenegro
24,000
March 28
AstraZeneca/Oxford
622,000
24,000
North Macedonia
250,380
February 7
Pfizer/BioNTech
2.1 million
312,780
Serbia
115,200
August 25
AstraZeneca/Oxford
6.9 million
292,800
Ukraine
1.0 million
January 19
Pfizer/BioNTech
44 million
8.8 million

ASIA & PACIFIC

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Afghanistan
2.0 million
February 2
J&J
39 million
9.0 million
Bangladesh
342,400
February 2
Pfizer/BioNTech
165 million
34.8 million
Brunei
24,000
April 2
AstraZeneca/Oxford
437,000
24,000
Cambodia
300,000
December 19
AstraZeneca/Oxford
17 million
2.9 million
East Timor
100,620
February 12
Pfizer/BioNTech
1.3 million
494,040
Fiji
50,400
November 18
Moderna
896,000
302,480
Indonesia
2.6 million
January 28
AstraZeneca/Oxford
274 million
48.8 million
Kiribati
56,000
August 21
AstraZeneca/Oxford
119,000
104,000
Kyrgyzstan
149,760
February 1
Pfizer/BioNTech
6.6 million
800,300
Laos
1.7 million
January 26
Pfizer/BioNTech
7.3 million
7.6 million
Malaysia
559,200
September 17
AstraZeneca/Oxford
32 million
1.4 million
Maldives
210,600
January 28
Pfizer/BioNTech
541,000
664,540
Mongolia
899,730
October 6
Pfizer/BioNTech
3.3 million
1.3 million
Nauru
7,200
April 2
AstraZeneca/Oxford
10,830
7,200
Nepal
800,000
February 7
AstraZeneca/Oxford
29 million
14.2 million
Pakistan
1.5 million
December 28
Moderna
221 million
39.1 million
Papua New Guinea
302,400
August 6
J&J
8.9 million
580,400
Philippines
769,860
March 3
Pfizer/BioNTech
110 million
52.6 million
Samoa
112,000
August 23
AstraZeneca/Oxford
198,410
136,000
Solomon Islands
100,620
November 16
Pfizer/BioNTech
687,000
209,420
Sri Lanka
820,000
December 20
Pfizer/BioNTech
22 million
5.0 million
Tajikistan
501,200
February 21
AstraZeneca/Oxford
9.5 million
5.4 million
Tonga
7,000
February 15
N/A
106,000
67,800
Tuvalu
4,800
April 8
AstraZeneca/Oxford
11,800
4,800
Uzbekistan
2.8 million
February 17
Moderna
34 million
12.7 million
Vanuatu
24,000
May 19
AstraZeneca/Oxford
307,000
24,000
Vietnam
6.3 million
January 25
Pfizer/BioNTech
97 million
38.7 million

AMERICAS

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Antigua and Barbuda
19,200
November 22
N/A
98,000
60,000
Argentina
960,400
October 12
AstraZeneca/Oxford
45 million
3.9 million
Bahamas
57,330
October 18
Pfizer/BioNTech
393,000
124,530
Barbados
14,040
December 16
Pfizer/BioNTech
287,000
114,840
Belize
58,500
October 26
Pfizer/BioNTech
398,000
159,300
Bermuda
9,600
April 6
AstraZeneca/Oxford
64,000
9,600
Bolivia
1.3 million
February 16
Pfizer/BioNTech
12 million
8.0 million
Brazil
2.0 million
September 20
Sinovac
213 million
11.9 million
Chile
331,000
May 20
AstraZeneca/Oxford
19 million
489,400
Colombia
117,000
March 1
Pfizer/BioNTech
51 million
16.6 million
Costa Rica
200,070
February 28
Pfizer/BioNTech
5.1 million
1.6 million
Dominica
30,240
February 4
Moderna
72,000
133,920
Dominican Republic
184,800
August 27
AstraZeneca/Oxford
11 million
463,200
Ecuador
1.5 million
February 15
Pfizer/BioNTech
18 million
3.8 million
El Salvador
188,370
August 27
Pfizer/BioNTech
6.5 million
3.6 million
Grenada
69,030
December 16
Pfizer/BioNTech
113,000
114,630
Guatemala
680,940
January 27
Pfizer/BioNTech
17 million
5.0 million
Guyana
28,800
January 14
J&J
787,000
291,540
Haiti
151,200
February 14
Moderna
11 million
1.1 million
Honduras
250,040
October 28
Moderna
9.9 million
4.8 million
Jamaica
100,000
February 21
AstraZeneca/Oxford
3.0 million
1.7 million
Mexico
4.0 million
March 4
AstraZeneca/Oxford
129 million
21.3 million
Nicaragua
993,600
January 24
J&J
6.6 million
4.7 million
Panama
74,400
September 15
AstraZeneca/Oxford
4.3 million
148,800
Paraguay
466,830
January 24
Pfizer/BioNTech
7.1 million
1.7 million
Peru
1.2 million
November 10
Sinopharm
33 million
3.6 million
Saint Kitts and Nevis
21,600
April 7
AstraZeneca/Oxford
53,000
21,600
Saint Lucia
7,200
December 28
J&J
184,000
197,430
Saint Vincent and the Grenadines
70,200
December 14
Pfizer/BioNTech
111,000
115,800
Suriname
64,800
December 14
AstraZeneca/Oxford
587,000
144,000
Trinidad and Tobago
84,000
November 27
Sinopharm
1.4 million
185,200
Uruguay
50,400
September 1
AstraZeneca/Oxford
3.5 million
148,800
Venezuela
3.1 million
January 17
Sinopharm
28 million
12.1 million

Sources: WHO, UNICEF, GAVI, releases from local authorities

###

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.511 seconds.